The Policy and Procedures of RARC are subject to change as ADNI progresses and further experience is gained.
One of the goals of ADNI is the collection of biospecimens, including blood, urine, and cerebrospinal fluid (CSF) from participants. An accounting of the biospecimens available through ADNI will be maintained on the ADNI website. Several analyses of general interest (homocysteine, species of isoprostanes, tau and Aβ) will be performed by the ADNI Biomarkers Core, with results made available on the ADNI web site as soon as the laboratory analyses are complete.
Interested investigators, whether associated with an ADNI site or not, are encouraged to apply for use of this limited resource. However, use of ADNI samples for technology development or comparisons among different technologies is not recommended for well established analytes unless there is preliminary data showing clearly superior performance.
Please note it is ADNI policy that if your application to obtain ADNI samples is approved by the RARC, ADNI will send you
these samples with a code number which does not permit you to link the samples to ADNI data. Once you have finished your
analyses, and performed QC, it also is ADNI policy that you send the results to Michael Donohue at ADCS and he will upload
the results to the ADNI database. Once these data are in the ADNI database you (and others) will be able to analyze
the data and relate the results to diagnosis and other features.